9 terminated. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Terminated 9 |
| Phase 2 | 2 | Terminated 2 |
Follow HIV Infection: new trials by email Literature Review of HIV Infection trials Research Report on HIV Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures Eltrombopag, Placebo - Non-alcoholic Steatohepatitis, Chronic Liver Disease | Phase 3 | Terminated | GlaxoSmithKline | 292 | 2008-06-01 | 2018-10-12 |
| MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED) MK0518 (raltegravir), Comparator: KALETRA™ (lopinavir (+) ritonavir ), Comparator: placebo - HIV Infection | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 352 | 2007-05-01 | 2017-03-21 |
| MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED) Comparator: raltegravir, Comparator: placebo, Comparator: lopinavir (+) ritonavir - HIV Infection | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 355 | 2007-05-01 | 2017-03-21 |
| Botswana Tenofovir Oral HIV Prophylaxis Trial Tenofovir Disoproxil Fumarate 300 mg daily - HIV Infection | Phase 2 / Phase 3 | Terminated | Centers for Disease Control and Prevention | 1200 | 2005-09-01 | 2007-03-19 |
| Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects GW873140 - HIV Infection | Phase 3 | Terminated | GlaxoSmithKline | 406 | 2005-07-01 | 2009-05-18 |
| Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects GW873140 - HIV Infection | Phase 3 | Terminated | GlaxoSmithKline | 18 | 2005-07-01 | 2011-03-29 |
| Cellulose Sulfate and HIV Transmission Among Women Cellulose Sulfate gel (6%) - HIV Infection | Phase 3 | Terminated | CONRAD | 1428 | 2005-07-01 | 2015-08-28 |
| Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 GW873140 - HIV Infection | Phase 3 | Terminated | GlaxoSmithKline | 2005-06-01 | 2011-03-29 | |
| Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV Isoniazid (INH), Trimethoprim/Sulfamethoxazole (TMP/SMX), Isoniazid Placebo (PL) - HIV Infection, Tuberculosis | Phase 2 / Phase 3 | Terminated | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 1354 | 2004-02-01 | 2019-02-05 |
HIV Infections (9) · Acquired Immunodeficiency Syndrome (1) · Hepatitis B (1) · Hepatitis C (1) · Jacobs syndrome (1) · Liver Diseases (1) · Non-alcoholic Fatty Liver Disease (1) · Pneumonia, Pneumocystis (1) · Sexually Transmitted Diseases (1) · Thrombocytopenia (1) · Tuberculosis (1)
Blood-Borne Infections (9) · Communicable Diseases (9) · Genital Diseases (9) · Immune System Diseases (9) · Immunologic Deficiency Syndromes (9) · Infections (9) · Lentivirus Infections (9) · RNA Virus Infections (9) · Retroviridae Infections (9) · Sexually Transmitted Diseases, Viral (9) · Urogenital Diseases (9) · Virus Diseases (9) · Sexually Transmitted Diseases (8) · Actinomycetales Infections (1) · Bacterial Infections (1)
aplaviroc (3) · Ritonavir (2) · Isoniazid (1) · Lopinavir (1) · Raltegravir Potassium (1) · Sulfamethoxazole (1) · Tenofovir (1) · Trimethoprim (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · eltrombopag (1) · lopinavir-ritonavir drug combination (1)
GlaxoSmithKline (4) · Merck Sharp & Dohme LLC (2) · CONRAD (1) · Centers for Disease Control and Prevention (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)
United States (4) · Belgium (3) · Botswana (2) · Canada (2) · Germany (2) · India (2) · South Africa (2) · Argentina (1) · Benin (1) · Denmark (1) · France (1) · Italy (1) · Pakistan (1) · Poland (1) · Russia (1)
Charles D. Mitchell, MD (1) · Dawn K Smith, MD, MS, MPH (1) · George McSherry, MD (1) · Lut Van Damme, MD, MSc, PhD (1) · Lynn A Paxton, MD, MPH (1) · Shabir Madhi, MD (1)
PMID 20074791, PMID 18230259, PMID 18669425, PMID 20607114, PMID 21048963, PMID 21732834, PMID 22913681, PMID 23657072, PMID 26872154
U01AI068632 (1)